Picture of Fuji Pharma Co logo

4554 Fuji Pharma Co Income Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedSmall CapSuper Stock

Annual income statement for Fuji Pharma Co, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.

2019
September 30th
2020
September 30th
2021
September 30th
2022
September 30th
2023
September 30th
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoYuho
Standards:
JAS
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue36,27933,79333,99035,42640,889
Cost of Revenue
Gross Profit15,79614,87214,75114,55916,515
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses32,31830,72330,67531,93736,787
Operating Profit3,9613,0703,3153,4894,102
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes3,9612,9183,3713,7234,399
Provision for Income Taxes
Net Income After Taxes2,9632,0862,4332,6973,436
Minority Interest
Net Income Before Extraordinary Items
Net Income2,9632,0862,4332,6973,436
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income2,9622,0852,4322,6963,435
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS11177.5102131147
Dividends per Share